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CLINICAL INQUIRIES
The most recent Cochrane Review
found that both VBAC and repeat low-
transverse cesarean section have benefits
and risks associated with them; however,
after reviewing the limited data, they
concluded that no trial exists to ade-
quately help women and their caregivers
make an informed decision between the
two.2 A strong theme in the Cochrane
Review, echoed in most reviews, was the
■ Evidence summary
Contrary to the goals of Healthy People
2010, the rate of cesarean sections is
increasing.1 The repeat cesarean rate for
low-risk women of all ages and racial
groups is now 88.7%, the highest rate
since the Centers for Disease Control and
Prevention (CDC) began tracking the sta-
tistic in 1989. Is VBAC safe, or is a trial of
labor no longer supported by the data? 
How safe is vaginal birth after cesarean
section for the mother and fetus?
Compared with planned repeat low-transverse
cesarean section, vaginal birth after cesarean 
section (VBAC) is not associated with increased
risk of maternal or neonatal mortality (strength of
recommendation [SOR]: B). Morbidity is slightly
increased, as evidenced by higher uterine 
rupture rates and some neonatal outcome 
measures (SOR: B). 
E V I D E N C E - B A S E D A N S W E R
Risks of C-section and labor must be considered 
when counseling regarding route of delivery
Another question to pose is: how safe is repeat
cesarean section for the mother and fetus? How
much do morbidity and mortality increase with
each new intra-abdominal procedure? Each time
the belly is opened there is new scar, with
increased likelihood of adhesions and potential for
future bowel obstruction. Consider these risks
when counseling regarding route of delivery. Risk
of uterine rupture appears to be higher in trials of
labor (and confers a statistically significant but
small increase in morbidity but not mortality).
However, the uterine scar can silently fail without
labor—as is sometimes discovered at a scheduled
repeat section, usually without untoward effects on
mother or fetus.
Remember that you are sending a young
woman home with a new baby to care for (along
with other children) and a major abdominal 
procedure (through an old scar) to recover from,
which one could certainly define as morbidity.
Cesarean section is an important tool, but we 
must be careful to practice best possible care and
consider all patient factors and preferences. And
data are still lacking to support the notion that
VBAC is unsafe.
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absence of high-quality prospective ran-
domized data.
In an attempt to quantify the risks of
VBAC, a systematic review determined
that attempted VBAC, compared with
repeat low-transverse cesarean section,
increased the risk of uterine rupture by 2.7
per 1000 cases (95% confidence interval
[CI], 0.73–4.73).3 This additional risk rate
is often quoted in VBAC reviews and was
cited in the Agency for Healthcare
Research and Quality evidence report; it is
based on 1 prospective, nonrandomized
cohort trial and 1 retrospective cohort
study.4,5
No randomized controlled trials exist
for determining maternal safety of VBAC,
although another recent systematic review
found 2 nonrandomized prospective trials
of sufficient quality to analyze. The
authors concluded there were “no statisti-
cally significant differences between
planned elective repeat cesarean section
and planned VBAC.”6 Upon closer review
in PubMed, one of the cited studies did not
study 312 patients for VBAC outcomes as
alleged; rather, it investigated patient atti-
tudes towards VBAC.7
Since publication of that review, a
large, multicenter, prospective, nonran-
domized trial involving 33,699 patients
found no significant difference between
VBAC and planned cesarean for hyster-
ectomy (0.2% vs 0.3%; odds ratio
[OR]=0.77; 95% CI, 0.51–1.17), maternal
death (0.02% vs 0.04%; OR=0.38; 95%
CI, 0.1–1.46), and neonatal death (0.08%
vs 0.05%; OR=1.82; 95% CI, 0.73–4.57).8
Significant associations were found for
uterine rupture rates in spontaneous labor
(24/6685 [0.4%] vs no cases; number
needed to harm [NNH]=279) and neona-
tal hypoxic-ischemic encephalopathy (0.46
cases per 1000 vs no cases; NNH=2174).8
A retrospective Canadian cohort trial
of 308,755 women also demonstrated an
association of VBAC with uterine rupture
(0.65% of trial-of-labor cases; OR=2.38;
95% CI, 2.12–2.67), and a trend towards
higher maternal mortality in the cesarean
group (1.6 per 100,000 for VBAC vs 5.6
per 100,000 for planned cesarean;
OR=0.32; 95% CI, 0.07–1.47).9
The effect of VBAC on neonatal mor-
bidity and mortality is unclear. In contrast
to the negative larger trial,8 a smaller retro-
spective cohort of 24,529 births found a
higher association of perinatal death for
trial of labor (adjusted OR=11.7; 95% CI,
1.4–101.6).10 The perinatal death rate was
similar to rates in nulliparous women.
Regarding morbidity, one retrospective
cohort trial showed VBAC was associated
with an increase in neonatal sepsis (1% vs
0%; CI not given) compared with planned
cesarean, but VBAC resulted in less tran-
sient tachypnea (5% vs 7%) and hyper-
bilirubinemia (2% vs 6%).11
Recommendations from others
Both the American College of Obstetricians
and Gynecologists and the Society of
Obstetricians and Gynecologists of
Canada state that women with 1 previous
low-transverse cesarean section should be
offered a trial of labor after appropriate
counseling of the risks and benefits.12,13
Furthermore, induction with oxytocin is
allowed, but the use of prostaglandins is
not recommended. Based on expert opin-
ion, both organizations encourage VBAC
only in institutions staffed with surgeons
and anesthesiologists immediately avail-
able to provide emergent cesarean.
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THE JOURNAL OF FAMILY PRACTICE uses 
a simplified rating system called the 
Strength of Recommendation Taxonomy
(SORT). More detailed information can 
be found in the February 2003 issue,
“Simplifying the language of patient care,”
pages 111–120.
Strength of Recommendation (SOR) ratings
are given for key recommendations for readers.
SORs should be based on the highest-quality 
evidence available.
A Recommendation based on consistent and 
good-quality patient–oriented evidence.
B Recommendation based on inconsistent or 
limited-quality patient-oriented evidence.
C Recommendation based on consensus, usual practice,
opinion, disease-oriented evidence, or case series for 
studies of diagnosis, treatment, prevention, or screening
Levels of evidence determine whether a study
measuring patient-oriented outcomes is of
good or limited quality, and whether the results
are consistent or inconsistent between studies.
STUDY QUALITY
1—Good-quality, patient-oriented evidence 
(eg, validated clinical decision rules, systematic reviews 
and meta-analyses of randomized controlled trials
[RCTs] with consistent results, high-quality RCTs, or
diagnostic cohort studies)
2—Lower-quality patient-oriented evidence 
(eg, unvalidated clinical decision rules, lower-quality 
clinical trials, retrospective cohort studies, case control
studies, case series)
3—Other evidence (eg, consensus guidelines, usual 
practice, opinion, case series for studies of diagnosis,
treatment, prevention, or screening)
Consistency across studies 
Consistent—Most studies found similar or at least 
coherent conclusions (coherence means that differences
are explainable); or If high-quality and up-to-date 
systematic reviews or meta-analyses exist, they support
the recommendation
Inconsistent—Considerable variation among study findings
and lack of coherence; or If high-quality and up-to-date 
systematic reviews or meta-analyses exist, they do not 
find consistent evidence in favor of the recommendation
Evidence-based medicine ratings
